CoraLite® Plus 488-conjugated CSNK2A2 Polyclonal antibody

CSNK2A2 Polyclonal Antibody for IF/ICC
Cat No. CL488-10606

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

IF/ICC

CSNK2A2, EC:2.7.11.1, CSNK2A 2, CSNK2A1

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  CoraLite® Plus 488
规格: 

-/ -


经过测试的应用

Positive IF/ICC detected inHepG2 cells
For other applications, we recommend the unconjugated version of this antibody, 10606-1-AP

推荐稀释比

应用推荐稀释比
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

CL488-10606 targets CSNK2A2 in IF/ICC applications and shows reactivity with human samples.

经测试应用 IF/ICC Application Description
经测试反应性 human
免疫原 CSNK2A2 fusion protein Ag0877 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 casein kinase 2, alpha prime polypeptide
别名 CSNK2A2, EC:2.7.11.1, CSNK2A 2, CSNK2A1
计算分子量 41 kDa
观测分子量 30-35 kDa
GenBank蛋白编号BC008812
基因名称 CSNK2A2
Gene ID (NCBI) 1459
RRIDAB_3672453
偶联类型 CoraLite® Plus 488 Fluorescent Dye
最大激发/发射波长493 nm / 522 nm
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDP19784
储存缓冲液 PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3
储存条件Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

CSNK2A2(Casein kinase II subunit alpha') is also named as CK2A3, CK2A2, CSNK2A1, CK2 and belongs to the protein kinase superfamily. It can function as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage during mitosis. It also can protect against ionizing radiation-induced apoptosis partly by phosphorylating and activating SIRT1. This protein has molecular weights between 35 kDa and 44 kDa(PMID:8622692).

实验方案

Product Specific Protocols
IF protocol for CL Plus 488 CSNK2A2 antibody CL488-10606Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...